Security National Trust’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.96M Hold
28,419
0.45% 68
2021
Q2
$1.96M Sell
28,419
-1,196
-4% -$79.9K 0.43% 70
2021
Q1
$1.91M Sell
29,615
-85
-0.3% -$5.48K 0.45% 69
2020
Q4
$1.73M Buy
29,700
+250
+0.8% +$15.1K 0.43% 68
2020
Q3
$1.86M Buy
29,450
+165
+0.6% +$11.4K 0.52% 63
2020
Q2
$2.25M Buy
29,285
+810
+3% +$62.1K 0.68% 53
2020
Q1
$2.13M Sell
28,475
-225
-0.8% -$15.5K 0.78% 44
2019
Q4
$1.86M Buy
28,700
+1,918
+7% +$125K 0.54% 60
2019
Q3
$1.7M Buy
26,782
+94
+0.4% +$6.14K 0.53% 59
2019
Q2
$1.8M Sell
26,688
-490
-2% -$32.2K 0.57% 56
2019
Q1
$1.77M Sell
27,178
-75
-0.3% -$4.99K 0.57% 62
2018
Q4
$1.71M Sell
27,253
-25
-0.1% -$1.75K 0.63% 59
2018
Q3
$2.11M Buy
27,278
+65
+0.2% +$4.91K 0.66% 54
2018
Q2
$1.93M Sell
27,213
-665
-2% -$47K 0.64% 53
2018
Q1
$2.1M Sell
27,878
-555
-2% -$44.1K 0.7% 47
2017
Q4
$2.04M Sell
28,433
-360
-1% -$27.3K 0.66% 50
2017
Q3
$2.33M Sell
28,793
-205
-0.7% -$15.7K 0.77% 43
2017
Q2
$2.05M Sell
28,998
-305
-1% -$20.3K 0.69% 50
2017
Q1
$1.99M Sell
29,303
-2,546
-8% -$179K 0.67% 48
2016
Q4
$2.28M Sell
31,849
-782
-2% -$58.1K 0.82% 36
2016
Q3
$2.58M Sell
32,631
-455
-1% -$37K 0.94% 33
2016
Q2
$2.76M Sell
33,086
-420
-1% -$37.3K 1.02% 29
2016
Q1
$3.08M Sell
33,506
-864
-3% -$77.9K 1.16% 25
2015
Q4
$3.48M Sell
34,370
-255
-0.7% -$26.5K 1.37% 21
2015
Q3
$3.4M Sell
34,625
-805
-2% -$89.4K 1.32% 21
2015
Q2
$4.15M Sell
35,430
-1,125
-3% -$123K 1.49% 16
2015
Q1
$3.59M Buy
36,555
+366
+1% +$37.2K 1.27% 25
2014
Q4
$3.41M Sell
36,189
-165
-0.5% -$17.1K 1.24% 26
2014
Q3
$3.87M Buy
36,354
+335
+0.9% +$32.8K 1.57% 12
2014
Q2
$2.99M Buy
36,019
+591
+2% +$46K 1.17% 29
2014
Q1
$2.51M Buy
35,428
+795
+2% +$62.4K 1.02% 33
2013
Q4
$2.6M Buy
34,633
+580
+2% +$40.4K 1.08% 31
2013
Q3
$2.14M Buy
34,053
+1,821
+6% +$109K 0.96% 35
2013
Q2
$1.65M Buy
+32,232
New +$1.68M 0.8% 38

Other funds holding GILD

Security National Trust's GILD Position: Q3 2021 in Review

Security National Trust held its Gilead Sciences (GILD) position steady in Q3 2021 at 28,419 shares worth $1.96M. The position accounts for 0.45% of the portfolio, ranked #68.

Security National Trust first reported a position in GILD in Q2 2013 and has held it in 34 quarters since. The position peaked at $4.15M in Q2 2015. 1,564 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

  • Security National Trust held 28,419 shares of Gilead Sciences worth $1.96M as of Q3 2021.
  • Security National Trust left its Gilead Sciences share count unchanged in Q3 2021.
  • Gilead Sciences made up 0.45% of Security National Trust's portfolio in Q3 2021, its #68 holding.
  • Security National Trust first reported a position in Gilead Sciences in Q2 2013 and has held it in 34 quarters since.
  • Security National Trust's Gilead Sciences position peaked at $4.15M in Q2 2015.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on Security National Trust's 13F filing for Q3 2021, filed 4 Oct 2021.